Key result
Higher pulse pressure coefficient of variation linked to ~3% greater HF risk per 1% increase.
Why the study?
In adult hypertensive patients, blood pressure variability is considered a risk factor for heart failure, but the relationship between pulse pressure variability and heart failure risk remains unclear.
Does higher visit-to-visit pulse pressure variability increase the risk of acute decompensated heart failure in hypertensive adults?
Observational (n=9,429)
Open-label
Yes
Does higher visit-to-visit pulse pressure variability increase the risk of acute decompensated heart failure in hypertensive adults?
Visit-to-visit pulse pressure variability is an independent risk factor for incident acute decompensated heart failure in hypertensive patients.
Answers are grounded in this paper and cite their sources.
May support pulse pressure variability assessment for heart failure risk stratification in hypertension; leaves open need for trials confirming causality and benefit.
OBJECTIVES: In adult hypertensive patients, blood pressure variability is considered a risk factor for heart failure. The relationship between pulse pressure variability and the risk of heart failure remains unclear. This study aims to explore the impact of pulse pressure variability (PPV) on heart failure through a secondary analysis of the SPRINT randomized controlled trial. METHODS: The data were derived from the SPRINT (Systolic Blood Pressure Intervention Trial) study. The trial recruited participants 50 years or older, with SBP ≥ 130 mm Hg and at least one additional CVD risk factor. We calculated pulse pressure based on the systolic and diastolic blood pressure obtained during follow-up, and used the coefficient of variation to represent pulse pressure variability (PPV) for statistical analysis. We considered the incidence of acute decompensated heart failure as the outcome measure. We employed multivariable Cox regression analysis to examine the relationship between PPV and the risk of heart failure occurrence. Additionally, we used a restricted cubic spline model to analyze the dose-response relationship between PPV and the risk of heart failure occurrence. RESULTS: In this study, a total of 9429 participants were included. During a median follow-up time of 3.87 years, 188 new cases of heart failure were observed. The mean age of the study population was 67.9 ± 9.4 years and 3382 participants (35.5%) were females. The average PPCV was 13.85 ± 5.37%. The results from the multivariable Cox regression analysis indicated that the risk of heart failure increased by 3% for every 1% increase in PPCV (HR = 1.030 [95% CI 1.016-1.044]; P < 0.001). CONCLUSIONS: The study found that PPV is an independent risk factor for the occurrence of heart failure. This underscores the importance of maintaining long-term stability in pulse pressure, in preventing the development of heart failure.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) conducted an observational in Hypertension (n=9,429). Pulse pressure variability (PPCV) vs. Low pulse pressure variability was evaluated on Incidence of acute decompensated heart failure (HR 1.030, 95% CI 1.016-1.044, p=<0.001). Every 1% increase in the pulse pressure coefficient of variation was associated with a 3% increased risk of heart failure in patients with hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: